Literature DB >> 4086263

Thymectomy for myasthenia gravis: a fourteen-year experience.

A Sghirlanzoni, R Mantegazza, D Peluchetti, F Fiacchino, L Morandi.   

Abstract

Over the last 14 years we have thymectomized 106 myasthenic patients, 62 by transcervical and 44 by transsternal approach. At the end of the follow-up 49 patients (46.2%) had improved, 12 of these (11.2%) being in remission. Our data supply no guidance regarding the prognosis of individual patients at the time of thymectomy. In our hands neither operation seemed to modify the natural course of myasthenia gravis.

Entities:  

Mesh：

Year:  1985        PMID： 4086263     DOI： 10.1007/BF02331034

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  16 in total

Review 1.  Thymectomy in myasthenia gravis: pathologic, clinical, and electrophysiologic correlations.

Authors:  A E Papatestas; G Genkins; S H Horowitz; P Kornfeld
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrman; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

3.  Myasthenia gravis: prolonged treatment with steroids.

Authors:  A Sghirlanzoni; D Peluchetti; R Mantegazza; F Fiacchino; F Cornelio
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

4.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

5.  The natural course of myasthenia gravis and effect of therapeutic measures.

Authors:  D Grob; N G Brunner; T Namba
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

6.  Effect of plasmapheresis in myasthenia gravis 1978-1980.

Authors:  M R Olarte; R S Schoenfeldt; A S Penn; R E Lovelace; L P Rowland
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

7.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

8.  Aspects of the natural history of myasthenia gravis: crisis and death.

Authors:  M S Cohen; D Younger
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

9.  Thymic abnormalities: antigen or antibody? Response to thymectomy in myasthenia gravis.

Authors:  A S Penn; A Jaretzki; M Wolff; H W Chang; V Tennyson
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

10.  Myasthenia gravis, autoantibodies, and HL-A antigens.

Authors:  T E Feltkamp; P M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet; A L van Rossum; J J van Loghem; H J Oosterhuis
Journal:  Br Med J       Date:  1974-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.